BerandaORINY • OTCMKTS
add
Orion Oyj Unsponsored Finland ADR
Tutup sebelumnya
$35,45
Rentang hari
$37,53 - $37,53
Rentang tahun
$21,10 - $37,53
Kapitalisasi pasar
9,11 M EUR
Volume Rata-Rata
149,00
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(EUR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Pendapatan | 354,60 jt | 14,94% |
Biaya operasional | 124,00 jt | 8,20% |
Laba bersih | 61,30 jt | 39,95% |
Margin laba bersih | 17,29 | 21,76% |
Penghasilan per saham | 0,44 | 41,94% |
EBITDA | 91,40 jt | 33,43% |
Tarif pajak efektif | 20,29% | — |
Neraca
Total aset
Total liabilitas
(EUR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 259,40 jt | 37,91% |
Total aset | 1,70 M | 16,50% |
Total liabilitas | 635,00 jt | -15,69% |
Total ekuitas | 1,07 M | — |
Saham yang beredar | 140,69 jt | — |
Harga terhadap nilai buku | 4,68 | — |
Tingkat pengembalian aset | 11,68% | — |
Tingkat pengembalian modal | 14,30% | — |
Arus Kas
Perubahan kas bersih
(EUR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Laba bersih | 61,30 jt | 39,95% |
Kas dari operasi | 77,40 jt | -29,64% |
Kas dari investasi | -16,30 jt | 23,11% |
Kas dari pembiayaan | -7,90 jt | -5,33% |
Perubahan kas bersih | 53,80 jt | -33,91% |
Arus kas bebas | 42,10 jt | -85,72% |
Tentang
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.
Orion's class A and B shares are listed on the Helsinki Stock Exchange. Wikipedia
CEO
Didirikan
1917
Situs
Karyawan
3.943